Ke-Wei Chen

Ke-Wei Chen

Auto-generated profile, based on publicly available information

Ke-Wei Chen

Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, P. R. China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in Chemical Reviews
Verified
Journal Article
Closed access
KCKe-Wei Chen
Ke-Wei Chen
TSTian-Yu Sun
Tian-Yu Sun
YWYun-Dong Wu
Yun-Dong Wu

30 April 2026 in Nature Communications
Verified
Journal Article
Open access
CWCui-Zhen Wang
Cui-Zhen Wang
HHHuisi Huang
Huisi Huang
ZHZhihui Hu
Zhihui Hu
LGLongwei Gao
Longwei Gao
ZLZhi-Qiao Lin
Zhi-Qiao Lin
JWJian-Bo Wang
Jian-Bo Wang
Gate residues, acting in concert with distal dynamic networks, are emerging as critical yet underexploited regulators of enzymatic catalysis. Here we show that conformational dynamics analysis of fluoroacetate dehalogenase RPA1163 reveals a gate-based allosteric pair (K181-W185) that governs substrate access and reactivity. Network engineering of this pair yields a double mutant with high turnover number for α-fluorophenylpropionic acid (turnover number > 2 × 10⁵), establishing gate-centric allostery as a generalizable design principle. Structural and molecular dynamics analyses show that the activity enhancement arises from stabilization of catalytically competent open states through long-range coupling. Extension of this strategy to three additional dehalogenases confirms the universality of gate-based dynamic rewiring. Leveraging this framework, we establish a robust biocatalytic platform for stereoselective synthesis of α-fluoro and α-hydroxy carboxylic acids, achieving high productivity (turnover number > 3.7 × 10⁶) and enabling decagram-scale preparation of pharmaceutically relevant intermediates with high yield and enantioselectivity. Together, these findings establish gate-residue allostery as a powerful concept in protein engineering, bridging conformational dynamics with translational biocatalysis.